Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» China
China
Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Thu, 01/23/20 - 12:12 pm
Amgen
Astellas
Japan
BeiGene
China
Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country
Endpoints
Thu, 01/23/20 - 12:11 pm
Roche
Kadcyla
China
breast cancer
antibody-drug conjugate
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Motley Fool
Tue, 01/21/20 - 11:43 pm
Wuhan Coronavirus
China
CDC
vaccines
Novavax
Drugmakers slash prices to be eligible for China’s bulk-buy program
CNBC
Mon, 01/20/20 - 10:12 pm
China
off-patent
bulk-buy
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
Fierce Biotech
Fri, 01/17/20 - 12:08 pm
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
BioSpace
Thu, 01/16/20 - 11:14 pm
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development
Xconomy
Mon, 01/6/20 - 10:28 am
China
CF PharmTech
respiratory disease
drug development
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
Mon, 01/6/20 - 10:23 am
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Sun, 01/5/20 - 07:07 pm
Pfizer
Merck
Prevnar 13
Gardasil
vaccines
China
Walvax
Amgen to Sell Cancer Drugs in China Thanks to $2.7B Deal with BeiGene
Xtalks
Fri, 01/3/20 - 10:51 pm
Amgen
BeiGene
oncology
China
Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market
Pharmaforum
Fri, 01/3/20 - 09:45 am
Boehringer Ingelheim
China
BeiGene
drug manufacturing
Four Major Biopharma Scandals in 2019
BioSpace
Thu, 01/2/20 - 10:44 am
scandal
Novartis
Zolgensma
data manipulation
China
CRISPR
IP theft
Purdue Pharma
Sackler family
oxycontin
Joinn Biologics nabs $60M to use for biologics capacity
Fierce Pharma
Thu, 12/19/19 - 01:01 pm
Joinn Biologics
China
CDMO
drug manufacturing
biologics
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
Pharmaforum
Thu, 12/12/19 - 11:10 am
trade
biologics
drug pricing
regulatory
Canada
Mexico
China
AZ’s Imfinzi approved in early lung cancer in China
Pharmaforum
Thu, 12/12/19 - 10:55 am
China
AstraZeneca
Imfinizi
non-small cell lung cancer
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Motley Fool
Wed, 12/4/19 - 09:57 am
Merck
Keytruda
vaccines
China
Drugs firms make massive discounts to get reimbursement in China
Pharmaforum
Fri, 11/29/19 - 02:33 pm
Roche
Novartis
China
reimbursement
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Mon, 11/25/19 - 09:47 am
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Brii bags rights to tuberculosis drug to further antibiotic push
Fierce Biotech
Thu, 11/21/19 - 10:25 am
Brii Biosciences
China
AN2 Therapeutics
tuberculosis
antibiotics
OxyContin maker thrives in China with abandoned U.S. tactics
Stat
Wed, 11/20/19 - 10:13 am
Purdue Pharma
Sackler family
China
oxycontin
opioids
opioid crisis
Mundipharma
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »